The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. OnKure Therapeutics Inc’s current trading price is -86.65% away from its 52-week high, while its distance from the 52-week low is 57.06%. The stock’s price range for this period has been between $1.70 and $20.00 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.75 million for the day, a number notably higher than the average daily volume of 0.15 million over the last three months.
The stock of OnKure Therapeutics Inc (OKUR) is currently priced at $2.67. In the last session, the stock climbed significantly, topping out at $34.0 after opening at $2.67. The day’s lowest price was $21.0 before the stock closed at $2.4.
In terms of market performance, OnKure Therapeutics Inc had a fairly uneven. The highest value for the stock in the past year was $20.00 on 10/07/24, and the lowest value was recorded at $1.70 on 05/13/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
OnKure Therapeutics Inc (OKUR) has experienced a quarterly rise of 45.90% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 36.12M and boasts a workforce of 46 employees.
OnKure Therapeutics Inc: What Analysts Are Saying
As of right now, 5 analysts are rating OnKure Therapeutics Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.65, with a change in price of -2.38. Similarly, OnKure Therapeutics Inc recorded 134,395 in trading volume during the last 100 days, posting a change of -47.13%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for OKUR stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.
OKUR Stock Stochastic Average
As of today, OnKure Therapeutics Inc’s raw stochastic average for the last 50 days stands at 61.31%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 81.72%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 55.61% and 33.67%, respectively.
OKUR Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The metric has seen a significant loss of -80.07% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -51.01%. Over the past 30 days, the price of OKUR has fallen by 7.23%. And in the last five days, it has surged by 32.84%.
